P.G. Watanabe

2.4k total citations
56 papers, 1.9k citations indexed

About

P.G. Watanabe is a scholar working on Cancer Research, Health, Toxicology and Mutagenesis and Molecular Biology. According to data from OpenAlex, P.G. Watanabe has authored 56 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Cancer Research, 15 papers in Health, Toxicology and Mutagenesis and 11 papers in Molecular Biology. Recurrent topics in P.G. Watanabe's work include Carcinogens and Genotoxicity Assessment (30 papers), Effects and risks of endocrine disrupting chemicals (11 papers) and Pesticide Exposure and Toxicity (7 papers). P.G. Watanabe is often cited by papers focused on Carcinogens and Genotoxicity Assessment (30 papers), Effects and risks of endocrine disrupting chemicals (11 papers) and Pesticide Exposure and Toxicity (7 papers). P.G. Watanabe collaborates with scholars based in United States, India and Canada. P.G. Watanabe's co-authors include P.J. Gehring, J.F. Quast, William T. Stott, F. Peter Guengerich, A.M. Schumann, T Fox, R. E. Hefner, Richard H. Reitz, Timothy L. Macdonald and Jeanne Y. Domoradzki and has published in prestigious journals such as Science, Biochemistry and Environmental Health Perspectives.

In The Last Decade

P.G. Watanabe

55 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P.G. Watanabe United States 25 956 596 497 363 217 56 1.9k
Richard H. Reitz United States 21 880 0.9× 705 1.2× 370 0.7× 376 1.0× 93 0.4× 36 1.7k
Charlotte Witmer United States 19 521 0.5× 329 0.6× 515 1.0× 402 1.1× 145 0.7× 41 1.5k
Michele A. Medinsky United States 26 959 1.0× 685 1.1× 431 0.9× 309 0.9× 85 0.4× 75 1.9k
Friedrich J. Wiebel Germany 30 873 0.9× 610 1.0× 943 1.9× 1.1k 3.0× 350 1.6× 85 2.6k
Melvin D. Reuber United States 24 604 0.6× 322 0.5× 580 1.2× 207 0.6× 191 0.9× 102 1.8k
James S. Felton United States 20 891 0.9× 472 0.8× 647 1.3× 453 1.2× 323 1.5× 37 1.9k
A.‐M. Camus France 21 757 0.8× 343 0.6× 617 1.2× 179 0.5× 130 0.6× 28 1.4k
Charlene A. McQueen United States 24 738 0.8× 379 0.6× 755 1.5× 234 0.6× 143 0.7× 66 1.8k
William Lijinsky United States 26 604 0.6× 572 1.0× 413 0.8× 83 0.2× 160 0.7× 86 1.9k
Karl P. Baetcke United States 15 534 0.6× 835 1.4× 505 1.0× 151 0.4× 152 0.7× 29 2.0k

Countries citing papers authored by P.G. Watanabe

Since Specialization
Citations

This map shows the geographic impact of P.G. Watanabe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P.G. Watanabe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P.G. Watanabe more than expected).

Fields of papers citing papers by P.G. Watanabe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P.G. Watanabe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P.G. Watanabe. The network helps show where P.G. Watanabe may publish in the future.

Co-authorship network of co-authors of P.G. Watanabe

This figure shows the co-authorship network connecting the top 25 collaborators of P.G. Watanabe. A scholar is included among the top collaborators of P.G. Watanabe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P.G. Watanabe. P.G. Watanabe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Frantz, Stephen W., et al.. (1990). Evaluation of a Flow-ThroughIn VitroSkin Penetration Chamber Method Using Acetone-Deposited Organic Solids. Journal of Toxicology Cutaneous and Ocular Toxicology. 9(4). 277–299. 10 indexed citations
2.
Hanley, Thomas R., et al.. (1989). Metabolism and disposition of ethylene carbonate in male Fischer 344 rats. Toxicology and Applied Pharmacology. 100(1). 24–31. 3 indexed citations
3.
Hanley, Thomas R. & P.G. Watanabe. (1985). Measurement of solid feed consumption patterns in neonatal rats by 141Ce-radiolabeled microspheres. Toxicology and Applied Pharmacology. 77(3). 496–500. 12 indexed citations
4.
Fox, T & P.G. Watanabe. (1985). Detection of a Cellular Oncogene in Spontaneous Liver Tumors of B6C3F1 Mice. Science. 228(4699). 596–597. 53 indexed citations
5.
Reitz, Richard H. & P.G. Watanabe. (1985). Mechanistic considerations in the formulation of carcinogenic risk estimations. 241–252.
6.
Ramsey, J.C., et al.. (1983). Relevance of experimental studies to human risk.. Environmental Health Perspectives. 52. 9–14. 6 indexed citations
7.
Koller, Loren D., et al.. (1983). Evaluation of ELISA for detectingin vivochemical immunomodulation. Journal of Toxicology and Environmental Health. 11(1). 15–22. 22 indexed citations
8.
Reitz, Richard H., A.M. Schumann, P.G. Watanabe, & P.J. Gehring. (1982). Genetic vs. Nongenetic Chemical Carcinogenesis and Risk Assessment. PubMed. 21. 425–438. 4 indexed citations
9.
Schumann, A.M., T Fox, & P.G. Watanabe. (1982). [14C]Methyl chloroform (1,1,1-trichloroethane): Pharmacokinetics in rats and mice following inhalation exposure. Toxicology and Applied Pharmacology. 62(3). 390–401. 32 indexed citations
10.
Stott, William T., J.F. Quast, & P.G. Watanabe. (1981). Differentiation of the mechanisms of oncogenicity of 1,4-dioxane and 1,3-hexachlorobutadiene in the rat. Toxicology and Applied Pharmacology. 60(2). 287–300. 55 indexed citations
11.
Watanabe, P.G., et al.. (1981). The importance of non-linear (dose-dependent) pharmacokinetics in hazard assessment.. PubMed. 1(2). 147–59. 11 indexed citations
12.
Schumann, A.M., J.F. Quast, & P.G. Watanabe. (1980). The pharmacokinetics and macromolecular interactions of perchloroethylene in mice and rats as related to oncogenicity. Toxicology and Applied Pharmacology. 55(2). 207–219. 85 indexed citations
13.
Gehring, P.J., et al.. (1979). RISK ASSESSMENT OF ENVIRONMENTAL CARCINOGENS UTILIZING PHARMACOKINETIC PARAMETERS. Annals of the New York Academy of Sciences. 329(1). 137–152. 10 indexed citations
14.
Guengerich, F. Peter, et al.. (1979). Activation of vinyl chloride to covalently bound metabolites: roles of 2-chloroethylene oxide and 2-chloroacetaldehyde. Biochemistry. 18(23). 5177–5182. 100 indexed citations
15.
Watanabe, P.G., et al.. (1978). Comparison of the fate of vinyl chloride following single and repeated exposure in rats. Toxicology and Applied Pharmacology. 44(2). 391–399. 16 indexed citations
16.
McKenna, Michael J., P.G. Watanabe, & P.J. Gehring. (1977). Pharmacokinetics of vinylidene chloride in the rat.. Environmental Health Perspectives. 21. 99–105. 32 indexed citations
17.
Watanabe, P.G. & P.J. Gehring. (1976). Dose-dependent fate of vinyl chloride and its possible relationship to oncogenicity in rats.. Environmental Health Perspectives. 17. 145–152. 24 indexed citations
18.
Watanabe, P.G., et al.. (1975). A gas‐chromatographic method for the preparation of 14C‐labeled vinyl chloride. Journal of Labelled Compounds. 11(4). 535–542. 9 indexed citations
19.
Hefner, R. E., P.G. Watanabe, & P.J. Gehring. (1975). Preliminary studies on the fate of inhaled vinyl chloride monomer (VCM) in rats.. Environmental Health Perspectives. 11. 85–95. 38 indexed citations
20.
Sharma, R. P. & P.G. Watanabe. (1974). Time related disposition of tri-o-tolyl phosphate (TOTP) and metabolites in chicken. Pharmacological Research Communications. 6(5). 475–484. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Richard H. Reitz Breakdown of academic impact, for papers by Charlotte Witmer Breakdown of academic impact, for papers by Michele A. Medinsky Breakdown of academic impact, for papers by Friedrich J. Wiebel Breakdown of academic impact, for papers by Melvin D. Reuber Breakdown of academic impact, for papers by James S. Felton Breakdown of academic impact, for papers by A.‐M. Camus Breakdown of academic impact, for papers by Charlene A. McQueen Breakdown of academic impact, for papers by William Lijinsky Breakdown of academic impact, for papers by Karl P. Baetcke
Rankless by CCL
2026